1. Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose‐response study. Issue 8 (28th February 2018) Authors: Schwarzer, R.; Kivaranovic, D.; Paternostro, R.; Mandorfer, M.; Reiberger, T.; Trauner, M.; Peck‐Radosavljevic, M.; Ferlitsch, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 8(2018) Page Start: 1162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension. Issue 4 (29th June 2018) Authors: Mandorfer, M.; Scheiner, B.; Stättermayer, A. F.; Schwabl, P.; Paternostro, R.; Bauer, D.; Schaefer, B.; Zoller, H.; Peck‐Radosavljevic, M.; Trauner, M.; Reiberger, T.; Ferenci, P.; Ferlitsch, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 48:Issue 4(2018) Page Start: 451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Non-alcoholic steatohepatitis is reflected by levels of systemic soluble TREM2 and limited by the recruitment of TREM2-positive macrophages to areas of lipid-induced tissue damage. (August 2022) Authors: Porsch, F.; Kiss, M.G.; Rajčić, D.; Papac-Milicevic, N.; Goederle, L.; Hladik, A.; Derdak, S.; Shaw, L.E.; Heintz, L.; Paternostro, R.; Farlik, M.; Knapp, S.; Krawczyk, M.; Trauner, M.; Bilban, M.; Wolf, D.; Binder, C.J.; Hendrikx, T. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension. Issue 1 (3rd November 2017) Authors: Schwarzer, R.; Kivaranovic, D.; Mandorfer, M.; Paternostro, R.; Wolrab, D.; Heinisch, B.; Reiberger, T.; Ferlitsch, M.; Gerner, C.; Trauner, M.; Peck‐Radosavljevic, M.; Ferlitsch, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 1(2018) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity. Issue 7 (29th January 2018) Authors: Mandorfer, M.; Schwabl, P.; Paternostro, R.; Pomej, K.; Bauer, D.; Thaler, J.; Ay, C.; Quehenberger, P.; Fritzer‐Szekeres, M.; Peck‐Radosavljevic, M.; Trauner, M.; Reiberger, T.; Ferlitsch, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 7(2018) Page Start: 980 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗